OAM
CPXX

Oxford Asset Management’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Oxford Asset Management’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-849,400
Closed -$25.6M – 956
2016
Q2 		$25.6M Buy
849,400
+667,323
+367% +$13.5M 0.84% 17
2016
Q1 		$2.01M Buy
+182,077
New +$597K 0.06% 374

Oxford Asset Management's CPXX Position: Q3 2016 in Review

Oxford Asset Management sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 849,400 shares — an estimated $25.6M sold.

Oxford Asset Management first reported a position in CPXX in Q1 2016 and held it in 2 quarters. The position peaked at $25.6M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Oxford Asset Management reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Oxford Asset Management sold 849,400 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $25.6M.
  • Oxford Asset Management first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q1 2016 and held it in 2 quarters.
  • Oxford Asset Management's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $25.6M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Oxford Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.